Using incipient lines of the Collaborative Cross (CC), a murine genetic reference population, we previously identified a quantitative trait loci (QTL) associated with low SARS-CoV titer. In this study, we integrated sequence information and RNA expression of genes within the QTL to identify mucin 4 (Muc4) as a high priority candidate for controlling SARS-CoV titer in the lung.
Abstract
Using incipient lines of the Collaborative Cross (CC), a murine genetic reference population, we previously identified a quantitative trait loci (QTL) associated with low SARS-CoV titer. In this study, we integrated sequence information and RNA expression of genes within the QTL to identify mucin 4 (Muc4) as a high priority candidate for controlling SARS-CoV titer in the lung.
To test this hypothesis, we infected Muc4 -/mice and found that female, but not male, Muc4 -/mice developed more weight loss and disease following infection with SARS-CoV. Female
Muc4 -/mice also had more difficulty breathing despite reduced lung pathology; however, no change in viral titers was observed. Comparing across viral families, studies with chikungunya virus, a mosquito-borne arthralgic virus, suggests that Muc4's impact on viral pathogenesis may be widespread. Although not confirming the original titer QTL, our data identifies a role for Muc4 in the SARS-CoV disease and viral pathogenesis.
Importance
Given the recent emergence of SARS-CoV-2, this work suggest that Muc4 expression plays a protective role in female mice not conserved in male mice following SARS-CoV infection. With the SARS-CoV-2 outbreak continuing, treatments that modulate or enhance Muc4 activity may provide an avenue for treatment and improved outcomes. In addition, the work highlights the importance of studying host factors including host genetics and biological sex as key parameters influencing infection and disease outcomes.
Introduction 1
Most viral infections present with an array of symptoms following human infection, 2 ranging from asymptomatic to self-limiting, chronic, and sometimes fatal disease. Some of this 3 diversity is mediated by age, sex, and other comorbidities, but these demographics do not 4 account for all of the variability in disease outcomes. Genome-wide association studies (GWAS) 5 and candidate gene studies have established a number of genes associated with human 6 susceptibility to infectious diseases, but are limited by the large populations required to detect 7 genetic effects and by existing knowledge gaps (Fellay et al., 2007; Ge et al., 2009; Lindesmith 8 et al., 2003; López et al., 2010) . Furthermore, during outbreak settings there is often limited 9 access to clinical samples from infected humans. Thus, host susceptibility allele identification is 10 oftentimes heavily compromised by situational expediency and new approaches are needed to 11 identify alleles that regulate emerging virus pathogenesis. 12
Severe acute respiratory syndrome virus (SARS-CoV) is a respiratory pathogen that first 13 emerged in the Guangdong Province of China in November 2002, and rapidly spread to 28 14 countries, resulting in over 8,000 cases with a 10% case fatality ratio. Results 47
Selection of Muc4 as a SARS-CoV disease associated gene 48
In earlier studies, incipient CC lines were used to identify four QTLs associated with 49 SARS-CoV phenotypes in female mice, one of which was mapped on the basis viral titer in the 50 lung at four DPI (Gralinski et al., 2015) . A subsequent study utilizing both male and female F2 51 mice derived from a highly susceptible and highly resistant CC mouse line identified five more 52 SARS-CoV-associated QTLs, three of which were mapped at least partially on the basis of viral 53 titer (Gralinski et al., 2017) . Located on chromosome 16 from nucleotides 31,583,769-54 36,719,997, the pre-CC QTL accounted for 22% of the variation in viral titer, which ranged from 55 over 10 8 PFU/lobe to below the limit of detection (10 2 PFU/lobe). The F2 QTLs, by comparison, 56
were located on chromosomes 18, 7, and 12 and explained 12.9%, 12.3%, and 5.4%, 57 respectively, of the observed variation in titers from high 10 2 to low 10 7 PFU/lobe. Thus, while 58 SARS-CoV titer in the lung is clearly influenced by multiple host genetic factors, the preCC QTL 59 on chromosome 16 was chosen for candidate gene selection and validation. Analysis of allele 60 effects revealed that the founder PWK/PhJ was the main driver of low SARS-CoV titer in the 61 lung ( Fig. 1A) , and PWK/PhJ also had lower titers than any other founder strain at four DPI 62 (Gralinski et al., 2015) . We therefore used private SNPs or In/Dels found in PWK/PhJ to reduce 63 the potential targets in the QTL to seven ncRNAs and 74 genes for downstream analysis. 64
To prioritize the list of ncRNAs and genes within the QTL, the relationship between RNA 65 transcript levels and viral titer in the lung was examined. Sixty seven preCC mice had both 66 microarray and titer data available, of which sixty had titers above the limit of detection 67 (Gralinski et al., 2015) . Of the 74 candidate genes, 54 had one or more probes on the 68 microarray (Table S4) Table S5 ). Using 70 infection data from the founder mice, Muc4 RNA expression levels mimicked the allelic effects 71 of the QTL with PWK/PhJ mice exhibiting low Muc4 RNA levels (Fig. 1C ). Other potential 72 targets included Lrrc33, Sec22a, Parp14, and Ildr1; however, these genes either have little 73 known linkage to viral replication and the immune response (e.g., Lrrc33, Sec22a, and Ildr1) or 74 the directionality of the correlation did not support their relationship to viral titer in the lung 75 were infected with SARS-CoV and examined over a four-day time course. Following infection, a 85 significant sex-based difference in weight loss between Muc4 -/and WT mice was observed 86 (Table S3 ). Female Muc4 -/and control were essentially indistinguishable through two DPI ( Fig.  87 2A). However, infected Muc4 -/females continued to lose weight through day four, with 42% (6 88 of 14) meeting euthanasia requirements (≥20% weight loss) and another 42% (6 of 14) requiring 89 increased observation (≥10% weight loss). In contrast, the WT mice held static between days 90 two and three and began to recover by day four, with no mice meeting the requirements for 91 euthanasia and only 13% (2 of 15) requiring increased observation by a margin of ≤0.1g. This 92 Muc4-driven difference in weight loss was not observed in male mice following infection with 93 SARS-CoV ( Fig. 2B) . 94
Muc4 has minimal impact on viral load 95
Next, the impact of Muc4 -/on SARS-CoV viral load was measured. Lung lobes from 96 male and female Muc4 -/and WT mice were harvested at two DPI, an acute timepoint previously 97 associated with high SARS-CoV titer (Sheahan et al., 2008) , and at four DPI, the timepoint at 98 which the QTL on chromosome 16 was mapped (Gralinski et al., 2015) . Surprisingly, despite 99 trends for higher mean viral loads in Muc4 -/mice on day 2 and day 4, virus titers were not 100 significantly different from WT mice at either timepoint ( Fig. 3A) . Similarly, despite differences in 101 weight loss, viral titer in the lung also exhibited no sex effect (Table S3 ). Given the distribution 102 of Muc4 in mucosal surfaces, viral load was further interrogated with IHC to determine whether 103
Muc4 might impact viral tropism in a way not readily determined by the measurement of 104 infectious virus per lobe. Upon examining SARS-CoV antigen staining, however, no significant 105 differences in antigen distribution were noted between Muc4 -/and WT mice in either airway or 106 parenchymal staining ( Fig. 3B and 3C ). Together, the results indicated that the loss of Muc4 had 107 minimal impact on SARS-CoV viral load or distribution. (Table S1) . 117
Lung function altered in Muc4-/-female mice 118
To further evaluate damage to the lung following infection, whole body plethysmography 119 was utilized to examine changes in pulmonary function (Fig. 5 ). Using only females, both WT 120 and Muc4 -/mice were challenged with a lower dose (10 4 PFU) to ensure their survival over the 121 full six day time course required to observe the onset, peak, and recovery of disordered lung 122 function following SARS-CoV challenge in mice (Menachery et al., 2015a) . Examining airway 123 resistance (penH), the time to peak expiratory flow relative to total expiratory time (rPEF), and 124 mid-tidal expiratory flow (EF50), all three measurements had statistically significant differences 125 between SARS-CoV-infected and mock-infected mice within the Muc4 -/and WT groups 126
( Supplementary Table S3 ). However, no Muc4-dependent differences in either penH ( Fig. 5A ) 127 or rPEF (Fig. 5B ) were observed following SARS-CoV infection. In contrast, while not reaching 128 statistical significance, EF50 trended higher in the Muc4 -/mice as compared to WT mice, 129 peaking at day three post-infection ( Fig. 5C ). These results show a shift in the early breathing 130 curve in Muc4 -/mice with more rapid exhalation and more labored breathing. These findings 131 may have been exacerbated with the original, higher dose, but that experiment was precluded 132 by the limited survival of Muc4 -/mice. Overall, the whole body plethysmography data indicate 133 more difficult breathing for female Muc4 -/mice relative to their WT counterparts following 134
SARS-CoV infection. 135

Muc4 -/mice have augmented inflammation 136
Changes in the cytokine and chemokine responses following infection of Muc4 -/and WT 137 mice were evaluated at two days post infection. While not significant when adjusted for multiple 138 comparisons (Table S3) , key inflammatory cytokines including IL-1β, TNF-α, and IL6 had 139 increased expression in Muc4 -/mice as compared to WT mice ( Fig. 6A-C) . Similarly, MIP-1α, 140
MCP-1, and KC also had augmented expression in Muc4 -/mice ( Fig. 6D-F) . Notably, the 141 increased values in Muc4 -/mice were maintained across both males and females. Together, the 142 results indicate that Muc4 -/mice have augmented inflammatory cytokine responses relative to 143 WT mice, which may contribute to observed differences in pathogenesis. 144
Muc4 impacts pathogenesis for an unrelated virus 145
Because Muc4 modulated SARS-CoV susceptibility independent of viral replication, a 146 cross-platform validation study was undertaken to begin assessing whether the Muc4 had 147 widespread importance in viral pathogenesis. Chinkungunya virus (CHIKV), an alphavirus, 148 causes inflammatory arthritis and swelling within the joints in human patients. Importantly, 149
Muc4 has been detected in synovial sarcomas in humans, thus presenting a novel tissue 150 environment and unrelated virus to test the impact of Muc4 (Doyle et al., 2011) . Male and 151 female WT and Muc4 -/mice were infected with CHIKV and monitored for swelling of the footpad 152 for seven days post infection (Fig. 7) . The WT mice have minimal early stage swelling, as was for the gene in augmented SARS-CoV pathogenesis. While virus titers trended higher in Muc4 -/-169 mice at day 2 and 4, there was no statistically significant change as compared to WT control 170 mice. However, in absolute terms the Muc4 -/mice did have a modest 62% higher titer on day 171 two and a 51% higher titer on day four as compared to WT, and it is possible that this difference 172 is biologically significant despite the lack of statistical significance as determined by p-value 173 (Lytsy et al., 2018; Vyas et al., 2015) . In addition, the loss of Muc4 was linked to enhanced 174 CHIKV disease in vivo. Together, this study highlights both the utility and the challenges in 175 transitioning from QTL hits to single-molecule studies. Our initial hypothesis for Muc4 to play a 176 role in controlling virus replication proved incorrect, or, at the very least, substantially more 177 complex than a simple, direct correlate; however, our exploration found a disease-interaction 178 that played a role in pathogenesis across multiple viruses. Muc4. Although speculative, it is possible that Muc4 functions not to modulate local viral 244 replication, but rather to limit disseminated disease. Clearly, more studies are needed to 245 unravel these complex interactions. Table S1 . Table S2 . 283
Lung Titration 284
Lung samples were thawed at 37° and lysed for 60 seconds at 6,000 rpm in a MagNA 285
Lyser (Roche, Mannheim, Germany). Debris was pelleted, and lung homogenate was serially 286 diluted 10-fold in PBS. Vero E6 cell monolayers in 6-well plates were infected with 200μl of 287 diluted lung homogenate (10 -1 -10 -6 ) for one hour at 37°C with 5% CO 2 . Monolayers were 288 overlaid with a semi-solid overlay containing MEM supplemented with 2% FBS (HyClone, 289
Logan, UT), pencicillin/streptomycin (Gibco, Grand Island, NY), and 0.8% agar (Lonza, 290
Rockland, ME). At two DPI plates were stained with neutral red (Fisher Scientific, Fair Lawn, 291 NJ) for approximately four hours and plaques were visualized with a light box. 292
Cytokine Analysis 293
Cytokine production was measured using the Bio-Plex Pro Mouse Cytokine 23-plex Assay (Bio-294
Rad, Hercules, CA) on the MAGPIX Multiplex Reader (Bio-Rad, Hercules, CA) according to the 295 manufacturer's instructions. Lung samples were homogenized and clarified as described for the 296 lung titration assay prior to analysis. 297
Histopathology and Immunohistochemistry 298
Formalin-fixed lobes were embedded in paraffin and 4μm sections were mounted on 299 Team, 2015) to determine the impact of mouse strain and sex. Transformed daily 327
Buxco results were similarly analyzed by two-way ANOVA to determine the impact of infection 328 and mouse strain. Daily results for all pathology-related data types (histopathology, weight 329 change, and footpad swelling) was analyzed by three-way ANOVA to determine the impact of 330 mouse strain, sex, and infection status. When three-way ANOVA results indicated significant 331 differences on the basis of sex (weight loss, histopathology, and footpad swelling), the strain-332 based differences between infected animals of a single sex were analyzed using multiple t-tests 333 with the Benjamini and Hochberg correction for false discoveries in Prism. All graphing was 334 done in Prism. A significance threshold of >0.05 after correction for multiple comparisons was 335 considered significant throughout all studies. The results of all statistical analyses are 336 summarized in Table S3 . 337
Data Availability 338
All phenotypic data associated with the infection of Muc4 -/mice and their WT 339 counterparts are summarized in Table S1 and S2. Muc4 -/mice are available upon request. 
